{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:25:17Z","timestamp":1784215517698,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08477-z","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:02:04Z","timestamp":1727431324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The optimal antibiotic treatment duration for community-acquired pneumonia in adults diagnosed in general practice in Denmark (CAP-D): an open-label, pragmatic, randomised controlled trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1578-5429","authenticated-orcid":false,"given":"Eskild","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Aabenhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene Plejdrup","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"8477_CR1","unstructured":"WHO. WHO antimicrobial resistance. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed 16-06- 2022."},{"key":"8477_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/antibiotics10060661","volume":"10","author":"L Bisgaard","year":"2021","unstructured":"Bisgaard L, Andersen CA, Jensen MSA, Bjerrum L, Hansen MP. Danish GPs\u2019 experiences when managing patients presenting to general practice with symptoms of acute lower respiratory tract infections: a qualitative study. Antibiotics (Basel). 2021;10:661. https:\/\/doi.org\/10.3390\/antibiotics10060661.","journal-title":"Antibiotics (Basel)."},{"key":"8477_CR3","unstructured":"Statens Serum Institut . DANMAP 2021. https:\/\/www.danmap.org\/reports\/2021. Accessed 01-07-2022."},{"key":"8477_CR4","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/jac\/dkx115","volume":"72","author":"R Aabenhus","year":"2017","unstructured":"Aabenhus R, Siersma V, Sandholdt H, K\u00f8ster-Rasmussen R, Hansen MP, Bjerrum L. Identifying practice-related factors for high-volume prescribers of antibiotics in Danish general practice. J Antimicrob Chemother. 2017;72:2385\u201391. https:\/\/doi.org\/10.1093\/jac\/dkx115.","journal-title":"J Antimicrob Chemother"},{"key":"8477_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/02813432.2017.1333321","volume":"35","author":"R Aabenhus","year":"2017","unstructured":"Aabenhus R, Hansen MP, Siersma V, Bjerrum L. Clinical indications for antibiotic use in Danish general practice: results from a nationwide electronic prescription database. Scand J Prim Health Care. 2017;35:162\u20139. https:\/\/doi.org\/10.1080\/02813432.2017.1333321.","journal-title":"Scand J Prim Health Care"},{"key":"8477_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/13814788.2019.1674279","volume":"26","author":"LS Hansen","year":"2020","unstructured":"Hansen LS, Lykkegaard J, Thomsen JL, Hansen MP. Acute lower respiratory tract infections: symptoms, findings and management in Danish general practice. Eur J Gen Practice. 2020;26:14\u201320. https:\/\/doi.org\/10.1080\/13814788.2019.1674279.","journal-title":"Eur J Gen Practice"},{"key":"8477_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12890-017-0404-8","volume":"17","author":"GB Egelund","year":"2017","unstructured":"Egelund GB, Jensen AV, Andersen SB, Petersen PT, Lindhardt BO, von Plessen C, et al. Penicillin treatment for patients with community-acquired pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med. 2017;17:66. https:\/\/doi.org\/10.1186\/s12890-017-0404-8.","journal-title":"BMC Pulm Med."},{"key":"8477_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.cmi.2018.02.004","volume":"24","author":"M Ieven","year":"2018","unstructured":"Ieven M, Coenen S, Loens K, Lammens C, Coenjaerts F, Vanderstraeten A, et al. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clin Microbiol Infect. 2018;24:1158\u201363. https:\/\/doi.org\/10.1016\/j.cmi.2018.02.004. doi: S1198-743X(18)30152-6 [pii]","journal-title":"Clin Microbiol Infect"},{"key":"8477_CR9","first-page":"547","volume":"57","author":"A Holm","year":"2007","unstructured":"Holm A, Nexoe J, Bistrup LA, Pedersen SS, Obel N, Nielsen LP, et al. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract. 2007;57:547\u201354.","journal-title":"Br J Gen Pract"},{"key":"8477_CR10","unstructured":"RADS. RADS rapport om nedre luftvejsinfektion. https:\/\/rads.dk\/media\/3995\/beh-antibiotika-lrti-quick-guide-267963.pdf. Accessed 07-07-2022."},{"key":"8477_CR11","unstructured":"DLS and DSI. Retningslinjer for h\u00e5ndtering af voksne patienter indlagt med pneumoni. https:\/\/lungemedicin.dk\/wp-content\/uploads\/2022\/01\/DLS_DSI_Pneumoni_2021_110122_CPF.pdf. Accessed 07-07-2022."},{"key":"8477_CR12","unstructured":"DSAM. DSAM - guideline for lower respiratory tract infection. https:\/\/www.dsam.dk\/vejledninger\/luftvejsinfektioner. Accessed 07\u201307- 2022."},{"key":"8477_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bcpt.13684","volume":"130","author":"L Eggers-Kaas","year":"2022","unstructured":"Eggers-Kaas L, Bisgaard L, Thomsen JL, Jarb\u00f8l DE, Llor C, Christensen MB, et al. Antibiotic treatment of community-acquired pneumonia: a questionnaire survey in Danish general practice. Basic Clin Pharmacol Toxicol. 2022;130:151\u20137. https:\/\/doi.org\/10.1111\/bcpt.13684.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8477_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.amjmed.2007.04.023","volume":"120","author":"JZ Li","year":"2007","unstructured":"Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007;120:783\u201390. https:\/\/doi.org\/10.1016\/j.amjmed.2007.04.023. doi: S0002-9343(07)00554-2 [pii]","journal-title":"Am J Med"},{"key":"8477_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/bcpt.13205","volume":"124","author":"K M\u00f8ller Gundersen","year":"2019","unstructured":"M\u00f8ller Gundersen K, Nygaard Jensen J, Bjerrum L, Hansen MP. Short-course vs long-course antibiotic treatment for community-acquired pneumonia: a literature review. Basic Clin Pharmacol Toxicol. 2019;124:550\u20139. https:\/\/doi.org\/10.1111\/bcpt.13205.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8477_CR16","doi-asserted-by":"publisher","first-page":"e00635","DOI":"10.1128\/AAC.00635-18","volume":"62","author":"GS Tansarli","year":"2018","unstructured":"Tansarli GS, Mylonakis E. Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults. Antimicrob Agents Chemother. 2018;62:e00635. https:\/\/doi.org\/10.1128\/AAC.00635-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"8477_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2165\/00003495-200868130-00004","volume":"68","author":"G Dimopoulos","year":"2008","unstructured":"Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, Grammatikos AP, Athanassa Z, Falagas ME. Short- versus long-course antibacterial therapy for community-acquired pneumonia\u202f: a meta-analysis. Drugs. 2008;68:1841\u201354. https:\/\/doi.org\/10.2165\/00003495-200868130-00004.","journal-title":"Drugs"},{"key":"8477_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11739-018-1955-2","volume":"14","author":"L Furlan","year":"2019","unstructured":"Furlan L, Erba L, Trombetta L, Sacco R, Colombo G, Casazza G, et al. Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign. Intern Emerg Med. 2019;14:377\u201394. https:\/\/doi.org\/10.1007\/s11739-018-1955-2.","journal-title":"Intern Emerg Med"},{"key":"8477_CR19","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","volume":"397","author":"A Dinh","year":"2021","unstructured":"Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, et al. Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021;397:1195\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(21)00313-5.","journal-title":"Lancet"},{"key":"8477_CR20","doi-asserted-by":"publisher","first-page":"CD009070","DOI":"10.1002\/14651858.CD009070.pub2","volume":"9","author":"J L\u00f3pez-Alcalde","year":"2018","unstructured":"L\u00f3pez-Alcalde J, Rodriguez-Barrientos R, Redondo-S\u00e1nchez J, Mu\u00f1oz-Guti\u00e9rrez J, Garc\u00eda JMM, Rodr\u00edguez-Fern\u00e1ndez C, et al. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev. 2018;9:CD009070. https:\/\/doi.org\/10.1002\/14651858.CD009070.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"8477_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/1740774518778027","volume":"15","author":"M Quartagno","year":"2018","unstructured":"Quartagno M, Walker AS, Carpenter JR, Phillips PP, Parmar MK. Rethinking non-inferiority: a practical trial design for optimising treatment duration. Clin Trials (London, England). 2018;15:477. https:\/\/doi.org\/10.1177\/1740774518778027.","journal-title":"Clin Trials (London, England)."},{"key":"8477_CR22","unstructured":"Anonymous nice guidelines pneumonia. 2022. https:\/\/www.nice.org.uk\/guidance\/cg191\/chapter\/1-Recommendations#presentation-with-lower-respiratory-tract-infection-2."},{"key":"8477_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jval.2013.06.011","volume":"16","author":"R Aabenhus","year":"2013","unstructured":"Aabenhus R, Thorsen H, Siersma V, Brodersen J. The development and validation of a multidimensional sum-scaling questionnaire to measure patient-reported outcomes in acute respiratory tract infections in primary care: the acute respiratory tract infection questionnaire. Value Health. 2013;16:987\u201392. https:\/\/doi.org\/10.1016\/j.jval.2013.06.011.","journal-title":"Value Health"},{"key":"8477_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x.","journal-title":"Br J Clin Pharmacol"},{"key":"8477_CR25","unstructured":"Anonymous REDCap. https:\/\/redcap.aau.dk\/. Accessed 12 Mar 2024."},{"key":"8477_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1536867X1701700305","volume":"17","author":"P Royston","year":"2017","unstructured":"Royston P. Model selection for univariable fractional polynomials. Stata J. 2017;17:619\u201329.","journal-title":"Stata J"},{"key":"8477_CR27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/1740774520944377","volume":"17","author":"M Quartagno","year":"2020","unstructured":"Quartagno M, Carpenter JR, Walker AS, Clements M, Parmar MK. The DURATIONS randomised trial design: estimation targets, analysis methods and operating characteristics. Clin Trials. 2020;17:644\u201353. https:\/\/doi.org\/10.1177\/1740774520944377.","journal-title":"Clin Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08477-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T21:03:18Z","timestamp":1727470998000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8477"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08477-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol is approved by <i>The Scientific Ethics Committee for the North Denmark Region<\/i> (N-20230039). The original approval was until April 2024, and extension of the recruitment period until March 2025 has been approved. The final approval and an English translation for both the original approval and the extension have been attached. All participants will receive oral and written information before consenting to participation. Written, informed consent will be obtained for both participation and for obtaining information from Shared Medical Record.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable\u2014no personal identifiable data of participants will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"627"}}